The design, synthesis, and evaluation of two universal doxorubicin-linkers: Preparation of conjugates that retain topoisomerase II activity

Monneret, 2001, Eur. J. Med. Chem., 36, 483, 10.1016/S0223-5234(01)01244-2 Minotti, 2004, Pharmacol. Rev., 56, 185, 10.1124/pr.56.2.6 Trail, 1993, Science, 261, 212, 10.1126/science.8327892 Nagy, 2000, Proc. Natl. Acad. Sci. U.S.A., 97, 829, 10.1073/pnas.97.2.829 Bosslet, 1998, Cancer Res., 58, 1195 Denmeade, 1998, Cancer Res., 58, 2537 Trouet, 1982, Proc. Natl. Acad. Sci. U.S.A., 79, 626, 10.1073/pnas.79.2.626 DeFeo-Jones, 2000, Nat. Med., 6, 1248, 10.1038/81351 Pasqualini, 2000, Cancer Res., 60, 722 Liu, 2003, Cancer Res., 63, 2957 Bakina, 1997, J. Med. Chem., 40, 4013, 10.1021/jm970066d Fenick, 1997, J. Med. Chem., 40, 2452, 10.1021/jm970237e Kasiotis, 2001, Steroids, 66, 785, 10.1016/S0039-128X(01)00110-6 Mazel, 2001, Anti-Cancer Drugs, 12, 107, 10.1097/00001813-200102000-00003 Allart, 2003, Bioconjug. Chem., 14, 187, 10.1021/bc0255992 Keller, 1975, Helv. Chim. Acta, 58, 531, 10.1002/hlca.19750580224 Dean, R. T.; Boutin, R. H.; Weber, R. W. U.S. Patent 5,144,043, 1992. Dess, 1983, J. Org. Chem., 48, 4155, 10.1021/jo00170a070 Bott, 1969, Chem. Commun., 22, 1304, 10.1039/C29690001304